Cassandra Voong
Internal Medicine · Augusta, GANPI 1144847864
Payments from drug & device makers
Across 150 payments — averaging $97.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Abbott$4K
- Biotronik Inc.$3K
- Abiomed$500
- Boston Scientific$237
- Cvrx, Inc.$229
- plus $766 from 19 others
What the payments were for
- Travel & lodging$8,27357%
- Food & beverage$6,30443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 54 | $5,941 |
| Abbott | 33 | $3,645 |
| Biotronik Inc. | 23 | $3,257 |
| Abiomed | 5 | $500 |
| Boston Scientific | 4 | $237 |
| Cvrx, Inc. | 1 | $229 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $126 |
| Heartflow, Inc. | 1 | $77 |
| Novartis | 3 | $64 |
| Inari Medical, Inc. | 3 | $61 |
| Ambu Inc. | 1 | $56 |
| Johnson & Johnson | 3 | $52 |
| Stryker | 2 | $44 |
| Teleflex LLC | 2 | $40 |
| Aurinia Pharma U.S., Inc. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Recor Medical Inc | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Asahi Intecc USA, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Cleerly, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MERLIN@HOME$1,331
- GALLANT$592
- Impella$415
- AZURE XT DR MRI SURESCAN$414
- ENSITE PRECISION$362
- Barostim Neo System$229
- Micra$190
- COREVALVE EVOLUT R$154
- WATCHMAN FLX$115
- AMPLATZER AMULET$114
How this compares
$14,577 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 17 | $12,487 |
| Carvedilol | 18 | $105 |
| Metoprolol Succinate | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $64 | $12,48717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Augusta
- Jon GibbsAugusta$172K
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.